Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Infections”

662 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 662 results

Not applicableLooking for participantsNCT04801862
What this trial is testing

Natural History of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionHealth Care Associated InfectionNosocomial Infection
Hospital Universitario de Valme 750
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Large-scale testing (Phase 3)Study completedNCT06120751
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Who this might be right for
Tetanus
CanSino Biologics Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Not applicableLooking for participantsNCT06311006
What this trial is testing

Safety Registry of a Fecal Microbiota Transplant Cohort

Who this might be right for
Clostridium Difficile Infections
Assistance Publique - Hôpitaux de Paris 305
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Testing effectiveness (Phase 2)UnknownNCT06580236
What this trial is testing

Study of the Drug B11-FC (Botulism Treatment)

Who this might be right for
Botulism
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 40
Large-scale testing (Phase 3)Study completedNCT01598311
What this trial is testing

CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 608
Post-approval studies (Phase 4)UnknownNCT04056728
What this trial is testing

A Phase IV Study to Assess the Safety of EupentaTM Inj

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type B Infection+2 more
LG Chem 3,000
Large-scale testing (Phase 3)Study completedNCT01917357
What this trial is testing

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 400
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Post-approval studies (Phase 4)UnknownNCT00877357
What this trial is testing

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Shantha Biotechnics Limited 3,000
Not applicableLooking for participantsNCT03562741
What this trial is testing

Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile

Who this might be right for
Clostridium Difficile Infection RecurrenceClostridium Difficile Infection
Krunal Patel 500
Early research (Phase 1)Study completedNCT01704937
What this trial is testing

Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum

Who this might be right for
Clostridium Difficile Infection
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00772343
What this trial is testing

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

Who this might be right for
DiarrheaClostridium Difficile Infection
Sanofi Pasteur, a Sanofi Company 116
Post-approval studies (Phase 4)WithdrawnNCT01552668
What this trial is testing

Fidaxomicin to Prevent Clostridium Difficile Colonization

Who this might be right for
Clostridium Difficile Infection
Washington University School of Medicine
Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Post-approval studies (Phase 4)Study completedNCT04090346
What this trial is testing

Fecal Microbiota Transplant

Who this might be right for
Clostridium Difficile Infection
Methodist Health System 24
Testing effectiveness (Phase 2)Study completedNCT03427229
What this trial is testing

Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection

Who this might be right for
Clostridium DifficilePseudomembranous Colitis
Catholic University of the Sacred Heart 58
Next Page